Dr. David Taggart (1958–2026): Forever the Guardian Angel of CABG

Back to Research Hub

Home
Research Hub
Dr. David Taggart (1958–2026): Forever t…

Dr. David Taggart (1958–2026): Forever the Guardian Angel of CABG

The Journal of Thoracic and Cardiovascular Surgery·September 4

Respiratory System Surgery Coronary Artery Disease Editorial / Obituary Obituary / Editorial Coronary Artery Bypass Grafting

Caveats

Level of evidence, sample size, study design, and all clinical fields are indeterminable from this document type.
No abstract or body text was provided — only bibliographic metadata. Structured extraction is not possible beyond the bibliographic level.
No clinical content, study design, sample size, or results are present in the provided text. All summary fields and tags have been left null or empty accordingly.

Show all 20

No study design, sample size, or evidence hierarchy can be assigned to an obituary/memorial article.
Study design, level of evidence, and sample size cannot be determined as this is not an empirical study.
Study design, level of evidence, and sample size tags cannot be assigned to a tribute/obituary article.
This appears to be an obituary or tribute piece for Dr. David Taggart, not a primary research study. No clinical data, outcomes, or methodology are present in the provided text. No meaningful clinical summary or evidence tags can be extracted.
This article appears to be an obituary or tribute piece for Dr. David Taggart, a prominent CABG surgeon, rather than a clinical research study. No patient data, study design, outcomes, or clinical findings are present in the provided text. All summary fields and clinical tags have been left null or omitted accordingly.
This article is an obituary or tribute piece commemorating Dr. David Taggart (1958–2026), a prominent cardiac surgeon and advocate for CABG. It contains no original research data, clinical outcomes, or comparative findings, and therefore cannot be meaningfully summarized for clinical evidence purposes
This article is an obituary or tribute piece honoring Dr. David Taggart (1958–2026), a prominent cardiac surgeon and advocate for CABG. It contains no original research data, clinical outcomes, or study population — no clinical evidence can be extracted from this paper
This is an obituary or memorial piece, not a primary research study. No clinical data, outcomes, or study populations are reported. It cannot be used to inform clinical decision-making directly
This paper appears to be an obituary or memorial tribute for Dr. David Taggart (1958–2026), a prominent advocate for coronary artery bypass grafting (CABG). It contains no original research data, clinical outcomes, or study methodology. No structured clinical summary, tags, or evidence-based content can be extracted. Suggested searches are based on the subject area implied by the tribute's title only.
This paper appears to be an obituary or memorial tribute for Dr. David Taggart (1958–2026), a prominent cardiac surgeon known for his work on CABG. It contains no clinical research data, patient outcomes, study design, or interventional findings to extract. All summary fields and tags have been left null or empty accordingly.
This paper appears to be an obituary or memorial tribute to Dr. David Taggart (1958–2026), a prominent CABG surgeon. It contains no original research data, clinical outcomes, study population, or interventional findings. All summary fields are set to null as there is no clinical or scientific content to extract. Tags and summary sections cannot be populated without source content.
This paper appears to be an obituary or tribute piece for Dr. David Taggart (1958–2026), a prominent advocate for CABG. It contains no original research data, study population, outcomes, or clinical findings to extract. All summary fields have been set to null accordingly.
This paper appears to be an obituary or tribute piece for Dr. David Taggart (1958–2026), a prominent CABG surgeon. It contains no clinical research data, study population, outcomes, or findings to summarize or tag.
This paper appears to be an obituary or tribute piece for Dr. David Taggart (1958–2026), a prominent CABG surgeon. It contains no original research data, clinical outcomes, patient population, or study methodology. No clinical summary, evidence tags, or findings can be extracted from the provided metadata alone.
This paper appears to be an obituary or tribute piece for Dr. David Taggart (1958–2026), a prominent cardiac surgeon known for his work on CABG. It does not contain original research, clinical trial data, patient populations, or measurable outcomes. No structured clinical summary, evidence tags, or level of evidence can be meaningfully extracted.
This paper appears to be an obituary or tribute piece for Dr. David Taggart, not a primary research article. There is no study population, intervention, comparator, or outcome data to extract. All summary fields and evidence tags have been left null or empty accordingly.
This paper appears to be an obituary or tribute piece honoring Dr. David Taggart (1958–2026), a prominent advocate for CABG. No original research data, clinical outcomes, patient populations, or study methods are present in the provided text. All structured summary fields have been set to null as no evidence-based content can be extracted.

Related Questions

Explore related topics

What are the long-term outcomes of bilateral internal mammary artery grafting in CABG?David Taggart contributions to coronary artery bypass grafting evidence David Taggart contributions to coronary artery bypass grafting outcomes What are the latest evidence-based guidelines for CABG graft selection?David Taggart contributions to coronary artery bypass grafting What are the long-term outcomes of CABG vs PCI in multivessel coronary artery disease?Bilateral internal mammary artery grafting evidence and survival benefit What is the current evidence for arterial revascularization strategies in coronary artery bypass surgery?What is the evidence for bilateral internal mammary artery grafting in CABG?Bilateral internal mammary artery grafting outcomes in CABG bilateral internal mammary artery grafting evidence and guidelines bilateral internal mammary artery grafting evidence and outcomes bilateral internal mammary artery grafting evidence and clinical guidelines bilateral internal mammary artery grafting outcomes CABG What is the role of arterial grafting in long-term CABG outcomes?arterial grafting versus saphenous vein graft evidence in CABG Arterial revascularization trials CABG outcomes landmark studies bilateral internal mammary artery CABG outcomes evidence arterial grafting versus vein grafting in CABG long-term survival arterial revascularization versus saphenous vein graft long-term survival How does bilateral internal mammary artery grafting compare to single arterial grafting in CABG?CABG versus PCI long-term outcomes in multivessel coronary artery disease bilateral internal mammary artery use in CABG long-term survival How has coronary artery bypass grafting technique evolved over the past two decades?arterial revascularization vs saphenous vein graft long-term survival arterial revascularization vs vein graft patency in CABG Best practices for CABG conduit selection based on current evidence arterial revascularization versus venous grafts in CABG long-term survival How does surgeon experience and technique affect CABG outcomes?arterial revascularization versus saphenous vein graft long-term survival CABG bilateral internal mammary artery CABG evidence and outcomes arterial revascularization versus vein graft CABG long-term survival Arterial revascularization trial results long-term CABG

Publication Details

Year: 2026
Journal: The Journal of Thoracic and Cardiovascular Surgery
Source: View article

Keep scrolling

More content below.

Up Next